Jinjian Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinjian Liu has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Jianfeng Liu
State Key Laboratory of Advanced Medical Materials and Devices Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Tianjin Institutes of Health Science, Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China
26 shared publications Yumin Zhang
Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Chinese Academy of Medical Sciences, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, PR China
20 shared publicationsLijun Yang
14 shared publications- Fan Huang
State Key Laboratory of Advanced Medical Materials and Devices Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Tianjin Institutes of Health Science, Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China
10 shared publications Chunhua Ren
6 shared publicationsJianfeng Liu
6 shared publications
Latest Publications
- Open Access
- 1 February 2027
- Published by KEAI Publishing in Bioactive Materials
- Vol. 68, 974-987
Calcium dysregulation in synergy with sonodynamic therapy via medroxyprogesterone-targeted and ROS-responsive nanoparticles for endometrial cancer
- 1 February 2027
- Published by KEAI Publishing in Bioactive Materials
- Vol. 68, 974-987
Open AccessCalcium dysregulation in synergy with sonodynamic therapy via medroxyprogesterone-targeted and ROS-responsive nanoparticles for endometrial cancer
- 14 January 2026
- Published by Elsevier in Journal of Controlled Release
- Vol. 391, 114634
Neutrophil-hijacking vesicles suppress NET-mediated metastasis via targeted siRNA delivery after radiotherapy
- 14 January 2026
- Published by Elsevier in Journal of Controlled Release
- Vol. 391, 114634
Neutrophil-hijacking vesicles suppress NET-mediated metastasis via targeted siRNA delivery after radiotherapy
- Open Access
- 29 May 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101916
A γ-ray responsive hydrogel “blasting fuse” for prevention of postoperative breast cancer recurrence and metastasis via radio-immunotherapy
- 29 May 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101916
Open AccessA γ-ray responsive hydrogel “blasting fuse” for prevention of postoperative breast cancer recurrence and metastasis via radio-immunotherapy
- 1 February 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 194, 80-97
Design and advances in antioxidant hydrogels for ROS-induced oxidative disease
- 1 February 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 194, 80-97
Design and advances in antioxidant hydrogels for ROS-induced oxidative disease
- Open Access
- 27 August 2024
- Published by Elsevier in Materials Today Bio
- Vol. 28, 101219
Injectable polypeptide-polysaccharide depot for preventing postoperative tumor recurrence by concurrent in situ chemotherapy and brachytherapy
- 27 August 2024
- Published by Elsevier in Materials Today Bio
- Vol. 28, 101219
Open AccessInjectable polypeptide-polysaccharide depot for preventing postoperative tumor recurrence by concurrent in situ chemotherapy and brachytherapy
- 14 June 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (25) , 32886
Correction to “Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy”
- 14 June 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (25) , 32886
Correction to “Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy”
- 15 April 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (5) , 3513
Correction to “Acid-Triggered in Situ Aggregation of Gold Nanoparticles for Multimodal Tumor Imaging and Photothermal Therapy”
- 15 April 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (5) , 3513
Correction to “Acid-Triggered in Situ Aggregation of Gold Nanoparticles for Multimodal Tumor Imaging and Photothermal Therapy”
- 15 February 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (8) , 11145
Correction to “Supramolecular Hydrogel Based on Chlorambucil and Peptide Drug for Cancer Combination Therapy”
- 15 February 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (8) , 11145
Correction to “Supramolecular Hydrogel Based on Chlorambucil and Peptide Drug for Cancer Combination Therapy”
- 8 June 2023
- Published by Elsevier in Nano Today
- Vol. 51
Pseudomonas aeruginosa targeting cascade photodynamic nanoassemblies for efficient antibacterial and anti-inflammatory therapy
- 8 June 2023
- Published by Elsevier in Nano Today
- Vol. 51
Pseudomonas aeruginosa targeting cascade photodynamic nanoassemblies for efficient antibacterial and anti-inflammatory therapy